abstract |
The present invention relates to recognition molecules which are directed against a survivin gene and its variants, and to the use of these recognition molecules for diagnosis, prophylaxis, reduction, follow-up control of diseases associated with cell growth, differentiation and / or division, such as tumor diseases , |